Zonisamide for Fibromyalgia & Migraine

• Status: Withdrawn
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients with fibromyalgia & migraine are randomized to receive zonisamide or placebo.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Pittsburgh
• Collaborator: Eisai Inc.
• Treatments: Zonisamide

Criteria

Inclusion Criteria:

• 18-65 with fibromyalgia & migraine

Exclusion Criteria:

• allergy sulfa, liver or kidney disease, pregnant or not using contraception